Option Care Health, Inc.
NASDAQ:OPCHMedical - Care Facilities
+$0.45 today
- Market cap
- $4.75B
- Beta
- 0.65
- P/E (TTM)
- 16.8
- EPS (TTM)
- $1.32
Volume 3.16M
Average 3.09M
OPCH Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Option Care Health, Inc.NASDAQ: OPCH
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures turns negative
Q3 FY2026 capital expenditures was -$6.68M, compared with $18.47M a year earlier. Trailing-twelve-month capital expenditures was -$25.15M. Over 3 fiscal years it compounded at +5.3% a year.
Context
- Capital expenditures amounted to 0.7% of revenue in FY2025, unchanged from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly capital expenditures holds near -$6.68M or moves back toward the trailing-twelve-month quarterly average of -$6.29M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (41.31M) USD
- Year-over-year change
- -16.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (41.31M) | -16.0% |
| FY2024 | 2024-12-31 | (35.61M) | +15.0% |
| FY2023 | 2023-12-31 | (41.87M) | -18.4% |
| FY2022 | 2022-12-31 | (35.36M) | -37.9% |
| FY2021 | 2021-12-31 | (25.63M) | — |
Capital Expenditures vs competitors
How OPCH compares with its peers on the latest reported figures
- OPCH's LTM Sep 2026 capital expenditures of $25.15M is the 4th largest of the 6 companies compared; the peer median is $66.35M.
- Its year-over-year change of +143.2% is the highest of 6, against a peer median of +19.9%.
- Capital expenditures amounts to 0.4% of revenue for OPCH, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $799.1M | +19.9% | +8.0% | 12.9% | |
| LTM Jun 2026 | $189.34M | +1.7% | +30.3% | 3.5% | |
| LTM Jun 2026 | $66.35M | +19.8% | +3.1% | 2.6% | |
| LTM Sep 2026 | $25.15M | +143.2% | +5.3% | 0.4% | |
| LTM Mar 2026 | $18.77M | +113.1% | +15.8% | 1.8% | |
| LTM Oct 2026 | $9.7M | +38.1% | -14.7% | 0.4% | |
| Peer median (excluding OPCH) | $66.35M | +19.9% | +8.0% | 2.6% | |
Competitors are the stored peer set for OPCH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 139.9M | 150.56M | 267.09M | 211.82M | 207.59M |
| Depreciation & Amortization | 68.8M | 65.43M | 62.2M | 63.5M | 70.69M |
| Deferred Income Tax | (30.37M) | 49.19M | 12.77M | 12.66M | 8.44M |
| Stock-Based Compensation | 9.58M | 16.78M | 30.48M | 36.14M | 39.96M |
| Change in Working Capital | (11.37M) | (29.78M) | (21.45M) | (20.25M) | (99.75M) |
| Accounts Receivables | (4.27M) | (36.89M) | 224K | (32.08M) | (54.59M) |
| Inventory | (22.7M) | (41.01M) | (51M) | (114.13M) | (81.47M) |
| Accounts Payables | (10.38M) | 98.89M | 47.7M | 183.4M | 19.52M |
| Other Working Capital | 25.98M | (50.76M) | (18.37M) | (57.44M) | 16.79M |
| Other Non-Cash Items | 32.03M | 15.36M | 20.21M | 19.52M | 31.52M |
| Operating Cash Flow | 208.57M | 267.55M | 371.3M | 323.39M | 258.45M |
| Capital Expenditures | (25.63M) | (35.36M) | (41.87M) | (35.61M) | (41.31M) |
| Acquisitions (Net) | (85.91M) | (87.36M) | (12.49M) | 0 | (117.25M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 14.67M | (2.15M) | (864K) | (2.53M) |
| Investing Cash Flow | (111.54M) | (108.05M) | (56.51M) | (36.47M) | (161.08M) |
| Debt Repayment | (76.84M) | (6M) | (6M) | 43.58M | 40.9M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (32K) | 0 | (250.26M) | (252.73M) | (309.95M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 21.27M | (8.87M) | (9.06M) | (8.25M) |
| Financing Cash Flow | (76.87M) | 15.27M | (265.13M) | (218.21M) | (277.31M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 20.16M | 174.76M | 49.66M | 68.72M | (179.94M) |
| Free Cash Flow | 182.94M | 232.19M | 329.43M | 287.79M | 217.14M |
Option Care Health, Inc.
NASDAQ:OPCH
Intrinsic Alpha fair value
Locked
Current Price
$31.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.